RDY Financial Statements From 2010 to 2024

RDY Stock  USD 75.49  0.25  0.33%   
Dr Reddys financial statements provide useful quarterly and yearly information to potential Dr Reddys Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Dr Reddys financial statements helps investors assess Dr Reddys' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Dr Reddys' valuation are summarized below:
Gross Profit
113.8 B
Profit Margin
0.1924
Market Capitalization
12.7 B
Enterprise Value Revenue
0.0442
Revenue
271.3 B
We have found one hundred twenty available fundamental measures for Dr Reddys, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to verify all of Dr Reddys latest market performance against the performance between 2010 and 2024 to make sure the company can sustain itself in the future.
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RDY main balance sheet or income statement drivers, such as Interest Expense of 1.7 B, Total Revenue of 296.9 B or Gross Profit of 245.1 B, as well as many exotic indicators such as Short Term Coverage Ratios of 4.3, Price Earnings Ratio of 18.85 or Price To Sales Ratio of 3.49. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
This module can also supplement Dr Reddys' financial leverage analysis and stock options assessment as well as various Dr Reddys Technical models . Check out the analysis of Dr Reddys Correlation against competitors.

Dr Reddys Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets206.1 B371.3 B298.8 B
Very volatile
Other Current Liabilities59 B56.2 B41.7 B
Very volatile
Total Current Liabilities68.3 B98.6 B98.8 B
Pretty Stable
Total Stockholder Equity281.2 B267.8 B187.5 B
Pretty Stable
Retained Earnings260.3 B247.9 B125.1 B
Slightly volatile
Accounts Payable15 B26.1 B21.8 B
Very volatile
Cash6.3 B6.6 B17.1 B
Slightly volatile
Other Assets8.6 B8.2 B5.8 B
Slightly volatile
Short Term Investments73.6 B70.1 B40.5 B
Pretty Stable
Inventory30.4 B56 B44.5 B
Very volatile
Total Liabilities88.4 B103.5 B122.2 B
Pretty Stable
Intangible Assets24 B35.3 B32 B
Very volatile
Common Stock1.1 B958 M1.3 B
Pretty Stable
Property Plant Equipment80.1 B76.2 B41.3 B
Slightly volatile
Short and Long Term Debt Total14.7 B15.5 B52.9 B
Slightly volatile
Other Liabilities3.1 B2.9 B2.3 B
Slightly volatile
Property Plant And Equipment Net54 B65 B71.8 B
Pretty Stable
Current Deferred Revenue1.7 B1.8 B1.2 B
Slightly volatile
Non Current Assets Total95.9 B136.4 B125.6 B
Very volatile
Non Currrent Assets Other15.4 B14.6 B6.1 B
Very volatile
Cash And Short Term Investments80.6 B76.8 B49.7 B
Very volatile
Net Receivables46.9 B83.4 B68 B
Very volatile
Good Will6.6 B6.3 B5.8 B
Pretty Stable
Common Stock Shares Outstanding175.2 M191.3 M167.4 M
Slightly volatile
Liabilities And Stockholders Equity215 B371.3 B300.1 B
Very volatile
Non Current Liabilities Total4.7 B4.9 B22.5 B
Slightly volatile
Other Current Assets9.8 B17.4 B14.5 B
Pretty Stable
Other Stockholder Equity18.2 B17.4 B17.3 B
Pretty Stable
Total Current Assets120.7 B234.9 B174.7 B
Very volatile
Short Term Debt27.5 B14 B36.5 B
Pretty Stable
Property Plant And Equipment Gross130.2 B137 B374.5 B
Slightly volatile
Net Tangible Assets102.9 B182.7 B101 B
Slightly volatile
Long Term Debt Total1.1 B1.2 B5.3 B
Pretty Stable
Capital Surpluse7.1 B6.4 B6.2 B
Slightly volatile
Cash And Equivalents2.8 B2.6 B1.9 B
Pretty Stable
Net Invested Capital220.8 B281.8 B196.2 B
Slightly volatile
Net Working Capital77.2 B136.3 B60.9 B
Slightly volatile
Capital Stock914.8 M958 M844.7 M
Slightly volatile

Dr Reddys Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue296.9 B282.8 B165.9 B
Slightly volatile
Gross Profit245.1 B233.4 B106.5 B
Slightly volatile
Operating Income116.3 B110.7 B40.3 B
Slightly volatile
Research Development23.4 B22.3 B15.3 B
Slightly volatile
Cost Of Revenue44.3 B49.3 B58.9 B
Slightly volatile
Income Before Tax73 B69.6 B30.3 B
Slightly volatile
Net Income Applicable To Common Shares54.4 B51.8 B18.3 B
Slightly volatile
Net Income54.4 B51.8 B23.1 B
Slightly volatile
Depreciation And Amortization15.1 B14.4 B10.1 B
Slightly volatile
Selling General Administrative39.7 B41.8 B20 B
Slightly volatile
Other Operating Expenses193.8 B184.6 B129.3 B
Slightly volatile
EBIT116.3 B110.7 B39.3 B
Slightly volatile
EBITDA131.4 B125.1 B49.4 B
Slightly volatile
Total Operating Expenses142 B135.3 B69.5 B
Slightly volatile
Interest Income1.5 B952.2 MB
Slightly volatile
Reconciled Depreciation13.5 B14.4 B12.2 B
Slightly volatile
Selling And Marketing Expenses47.6 B53.5 B58.3 B
Slightly volatile

Dr Reddys Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Dividends PaidB5.7 B3.7 B
Slightly volatile
Capital Expenditures22.8 B21.7 B14.5 B
Slightly volatile
Total Cash From Operating Activities71.1 B67.7 B31.7 B
Slightly volatile
Net Income73 B69.6 B26.7 B
Slightly volatile
End Period Cash Flow6.3 B6.6 BB
Slightly volatile
Stock Based Compensation339.4 M357.3 M426.9 M
Slightly volatile
Begin Period Cash Flow17.9 B17.1 B7.5 B
Slightly volatile
Depreciation15.1 B14.4 B10.1 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Short Term Coverage Ratios4.35.551.7544
Slightly volatile
Price Earnings Ratio18.8519.8427.0019
Pretty Stable
Price To Sales Ratio3.493.643.2153
Slightly volatile
Dividend Yield0.00550.00580.0071
Pretty Stable
Operating Cycle283469448
Pretty Stable
Price Book Value Ratio4.23.843.8606
Pretty Stable
Days Of Payables Outstanding88.53174136
Pretty Stable
Operating Cash Flow Per Share334318177
Slightly volatile
Dividend Payout Ratio0.120.130.1922
Pretty Stable
Price To Operating Cash Flows Ratio24.8415.1921.4348
Slightly volatile
Pretax Profit Margin0.110.220.1581
Very volatile
Inventory Turnover0.961.011.888
Slightly volatile
Ebt Per Ebit1.030.720.9044
Slightly volatile
Payables Turnover2.072.184.3246
Slightly volatile
Operating Profit Margin0.370.350.2061
Slightly volatile
Company Equity Multiplier1.951.591.7467
Slightly volatile
Long Term Debt To Capitalization0.0060.00630.0893
Slightly volatile
Cash Per Share379361329
Pretty Stable
Total Debt To Capitalization0.05970.06290.2217
Slightly volatile
Return On Capital Employed0.380.370.2127
Slightly volatile
Payout Ratio0.120.130.1922
Pretty Stable
Debt Equity Ratio0.06320.06650.3141
Slightly volatile
Ebit Per Revenue0.370.350.2061
Slightly volatile
Quick Ratio1.621.871.3568
Pretty Stable
Net Income Per E B T0.990.860.7957
Slightly volatile
Cash Ratio0.07370.07750.2231
Slightly volatile
Cash Conversion Cycle195296312
Pretty Stable
Operating Cash Flow Sales Ratio0.130.220.1644
Slightly volatile
Days Of Inventory Outstanding391373291
Very volatile
Days Of Sales Outstanding10996.84171
Slightly volatile
Cash Flow Coverage Ratios3.25.031.3626
Slightly volatile
Price To Book Ratio4.23.843.8606
Pretty Stable
Current Ratio2.262.741.8362
Slightly volatile
Fixed Asset Turnover3.435.03.0781
Slightly volatile
Price Cash Flow Ratio24.8415.1921.4348
Slightly volatile
Enterprise Value Multiple7.898.317.8534
Slightly volatile
Debt Ratio0.04560.0480.1722
Slightly volatile
Cash Flow To Debt Ratio3.25.031.3626
Slightly volatile
Price Sales Ratio3.493.643.2153
Slightly volatile
Return On Assets0.08830.160.0885
Slightly volatile
Receivables Turnover4.383.93.2025
Slightly volatile
Asset Turnover0.780.880.7107
Pretty Stable
Net Profit Margin0.120.210.1269
Pretty Stable
Gross Profit Margin0.440.740.57
Slightly volatile
Price Fair Value4.23.843.8606
Pretty Stable
Return On Equity0.140.220.1477
Very volatile

RDY Fundamental Market Drivers

Forward Price Earnings20.4082
Cash And Short Term Investments66.7 B

RDY Upcoming Events

31st of January 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Dr Reddys Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dr Reddys income statement, its balance sheet, and the statement of cash flows. Dr Reddys investors use historical funamental indicators, such as Dr Reddys's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dr Reddys investors may use each financial statement separately, they are all related. The changes in Dr Reddys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dr Reddys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dr Reddys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue1.8 B1.7 B
Total Revenue282.8 B296.9 B
Cost Of Revenue49.3 B44.3 B
Ebit Per Revenue 0.35  0.37 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dr Reddys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dr Reddys' short interest history, or implied volatility extrapolated from Dr Reddys options trading.

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out the analysis of Dr Reddys Correlation against competitors.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.78
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.